Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus activity with FLT-PET in metastatic renal cell carcinoma
2009-012802-38Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temsirolimus in renal cell carcinoma (RCC), sponsored by Radboud University Medical Center. Primary endpoints: Objective response rate and Progression-free survival duration. Started May 2009; status: completed.
02
Drugs
temsirolimus
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on 2009-012802-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012802-38.